Literature DB >> 20195786

The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.

Jeremy Micah Crook1, Derek Hei, Glyn Stacey.   

Abstract

The International Stem Cell Banking Initiative (ISCBI) aims to create a global network of stem cell banks to facilitate best practice in stem cell research and clinical cell delivery, primary objectives of national and local governments worldwide and stem cell organizations such the International Stem Cell Forum and the International Society of Stem Cell Research. This paper is a brief overview of ISCBI, its primary activities, potential network participants, and the challenges for harmonizing stem cell banking on a global level.

Entities:  

Mesh：

Year:  2010        PMID： 20195786     DOI： 10.1007/s11626-010-9301-7

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


  5 in total

Review 1.  The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines.

Authors:  Lyn Healy; Charles Hunt; Lesley Young; Glyn Stacey
Journal:  Adv Drug Deliv Rev       Date:  2005-11-10       Impact factor: 15.470

2.  The generation of six clinical-grade human embryonic stem cell lines.

Authors:  Jeremy Micah Crook; Teija Tuulikki Peura; Lucy Kravets; Alexis Gina Bosman; Jeremy James Buzzard; Rachel Horne; Hannes Hentze; Norris Ray Dunn; Robert Zweigerdt; Florence Chua; Alan Upshall; Alan Colman
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

3.  Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.

Authors: 
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

4.  International banking: checks, deposits, and withdrawals.

Authors:  Lyn E Healy; Tenneille E Ludwig; Andre Choo
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

5.  The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research.

Authors:  Shirani Sivarajah; Grace Selva Raj; Adam Joshua Varughese Mathews; Norliza Binte Esmail Sahib; Wei Sek Hwang; Jeremy Micah Crook
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416
  5 in total
  17 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

Review 2.  Redefining the concept of standardization for pluripotent stem cells.

Authors:  Shintaro Sengoku; Koichi Sumikura; Toshihiko Oki; Norio Nakatsuji
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.

Authors: 
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

4.  Characterization of pluripotent stem cells.

Authors:  Mercè Martí; Lola Mulero; Cristina Pardo; Cristina Morera; Meritxell Carrió; Leopoldo Laricchia-Robbio; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2013-01-10       Impact factor: 13.491

Review 5.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Authors:  Kevin G Chen; Barbara S Mallon; Ronald D G McKay; Pamela G Robey
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

Review 6.  Allogenic banking of dental pulp stem cells for innovative therapeutics.

Authors:  Pierre-Yves Collart-Dutilleul; Franck Chaubron; John De Vos; Frédéric J Cuisinier
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

Review 7.  Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges.

Authors:  Ali Golchin; Alexia Chatziparasidou; Parviz Ranjbarvan; Zahra Niknam; Abdolreza Ardeshirylajimi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.

Authors:  Shelly E Tannenbaum; Tikva Tako Turetsky; Orna Singer; Einat Aizenman; Sophie Kirshberg; Nili Ilouz; Yaniv Gil; Yael Berman-Zaken; Temima Schnitzer Perlman; Nitshia Geva; Ora Levy; Daniel Arbell; Alex Simon; Assaf Ben-Meir; Yoel Shufaro; Neri Laufer; Benjamin E Reubinoff
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 9.  The promise of human embryonic stem cells in aging-associated diseases.

Authors:  Odessa Yabut; Harold S Bernstein
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

Review 10.  Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.

Authors:  Muhammad Sadeqi Nezhad; Meghdad Abdollahpour-Alitappeh; Behzad Rezaei; Mahboubeh Yazdanifar; Alexander Marcus Seifalian
Journal:  Pharm Res       Date:  2021-06-10       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.